Loading
Life sciences · Journal article
Cureus · October 3, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Residual axillary disease after an incomplete axillary lymph node dissection in breast cancer poses a management challenge.We report a 46-year-old female with left breast invasive ductal carcinoma who presented two months after modified radical mastectomy with bulky residual axillary nodes.PET-CT revealed metabolically active nodes suspicious for metastasis.After multidisciplinary discussion, completion axillary lymph node dissection (cALND) was performed, yielding two metastatic nodes out of six.The postoperative course was uneventful, and the patient proceeded to systemic therapy.For limited residual disease, regional nodal irradiation plus systemic therapy may achieve comparable local control with reduced morbidity, whereas bulky disease may justify surgical clearance for accurate staging and local control.This case highlights the role of cALND in young patients with significant residual nodal disease, emphasizing individualized, multidisciplinary decision-making based on disease burden, radiation quality, and systemic therapy.